Integrated DX is a proud provider of industry-leading pharmacogenomic testing options, that are an integral part of the healthcare systems continued growth. Pharmacogenomics (sometimes called pharmacogenetics) studies how a patient’s genes affect their response to various medications. Integrated DX’s testing options target up to 56 gene variants. Applying this evidence-based approach improves customized patient care, with fitted medication regimens and minimized cost related to trial-and-error. This is precision medicine.

Integrated DX provides our clients with test results in a complete and simple format. These results can be easily added to a patient’s EHR for future reference. We continue to develop and deliver an ever-expanding menu of new pharmacogenomic options.